Cachan, France

Peter Hicks

This inventor holds 2 USPTO granted patents. Top assignee: Synthelabo. Active years: 1990-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1990-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cardiovascular Treatments by Peter Hicks

Introduction

Peter Hicks is a notable inventor based in Cachan, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cardiovascular disorders. With a total of 2 patents to his name, Hicks has focused on innovative solutions for hypertension and related conditions.

Latest Patents

Hicks' latest patents include a pharmaceutical composition containing diltiazem, which is designed for the treatment of hypertension, cardiac insufficiency, and coronary insufficiency. Another notable patent involves pharmaceutical compositions that combine an alpha-blocker and a calcium antagonist, which are particularly useful in managing cardiovascular disorders, especially hypertension.

Career Highlights

Peter Hicks has been associated with Synthelabo, a company known for its advancements in pharmaceutical research and development. His work has contributed to the understanding and treatment of cardiovascular diseases, showcasing his commitment to improving patient outcomes through innovative therapies.

Collaborations

Hicks has collaborated with esteemed colleagues such as Icilio A Cavero and Jean-Claude Muller. These partnerships have further enhanced the research and development of effective pharmaceutical compositions.

Conclusion

Peter Hicks stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of cardiovascular treatments. His innovative patents reflect his dedication to advancing medical science and improving health outcomes for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…